WallStreetZenWallStreetZen

NASDAQ: INDP
Indaptus Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for INDP

Based on 1 analyst offering 12 month price targets for Indaptus Therapeutics Inc.
Min Forecast
$12.00+561.16%
Avg Forecast
$12.00+561.16%
Max Forecast
$12.00+561.16%

Should I buy or sell INDP stock?

Based on 1 analyst offering ratings for Indaptus Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their INDP stock forecasts and price targets.

INDP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 1%
1
BuyMaintains$12.00+561.16%2023-03-20

1 of 1

INDP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
INDP$1.82$12.00+561.16%Buy
LEXX$2.56N/AN/A
EFTR$0.36$4.00+1,001.93%Buy
COCP$1.85$35.00+1,791.89%Buy
ANGN$0.51N/AN/A

Indaptus Therapeutics Stock Forecast FAQ

Is Indaptus Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: INDP) stock is to Buy INDP stock.

Out of 1 analyst, 0 (0%) are recommending INDP as a Strong Buy, 1 (100%) are recommending INDP as a Buy, 0 (0%) are recommending INDP as a Hold, 0 (0%) are recommending INDP as a Sell, and 0 (0%) are recommending INDP as a Strong Sell.

If you're new to stock investing, here's how to buy Indaptus Therapeutics stock.

What is INDP's Price Target?

According to 1 Wall Street analyst that have issued a 1 year INDP price target, the average INDP price target is $12.00, with the highest INDP stock price forecast at $12.00 and the lowest INDP stock price forecast at $12.00.

The Wall Street analyst predicted that Indaptus Therapeutics's share price could reach $12.00 by Mar 20, 2024. The average Indaptus Therapeutics stock price prediction forecasts a potential upside of 561.16% from the current INDP share price of $1.82.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.